NICHE

Costs and effects of HIV/AIDS treatment in South Africa and Ghana

The Bill and Melinda Gates Foundation recently awarded € 150,000 for research into the costs and effects of antiretroviral drugs in Ghana and South Africa. NICHE will carry out the research in Ghana and works together with local partners in Ghana and the Erasmus MC. Erasmus MC and Brown University take the lead in a similar study in South Africa.

Staff Members involved:

• Dr. Rob Baltussen
  
• Dr. Jan Hontelez
  
• Ms. Evelinn Mikkelsen
  

Related publications:

• Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
• Balancing efficiency, equity and feasibility of HIV treatment in South Africa -- development of programmatic guidance.
• Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study
• HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making
• HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
• The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa